IL115641A0 - Quinoxalines a process for their preparation and their use - Google Patents

Quinoxalines a process for their preparation and their use

Info

Publication number: IL115641A0
Authority: IL; Israel
Prior art keywords: alkoxy; quinoxalines; preparation; formula; carbonyl
Prior art date: 1994-10-19

Application number

IL11564195A

Other languages

English (en)

Inventor

Manfred Dr Roesner

Uta-Maria Billhardt-Troughton

Reinhard Dr Kirsch

Joerg-Peter Dr Kleim

Christoph Dr Meichsner

Guenther Dr Ries

Irvin Dr Winkler

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-19

Filing date

1995-10-15

Publication date

1996-01-19

1995-10-15 Application filed by Hoechst Ag filed Critical Hoechst Ag

1996-01-19 Publication of IL115641A0 publication Critical patent/IL115641A0/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Compounds Of Unknown Constitution (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Dental Preparations (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

IL11564195A 1994-10-19 1995-10-15 Quinoxalines a process for their preparation and their use IL115641A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4437406A DE4437406A1 (de)	1994-10-19	1994-10-19	Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number	Publication Date
IL115641A0 true IL115641A0 (en)	1996-01-19

Family

ID=6531202

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL11564195A IL115641A0 (en)	1994-10-19	1995-10-15	Quinoxalines a process for their preparation and their use

Country Status (27)

Country	Link
US (1)	US5723461A (pt)
EP (1)	EP0708093B1 (pt)
JP (1)	JPH08225544A (pt)
KR (1)	KR960014108A (pt)
CN (1)	CN1094930C (pt)
AT (1)	ATE198747T1 (pt)
AU (1)	AU708293B2 (pt)
BR (1)	BR9504456A (pt)
CA (1)	CA2160859A1 (pt)
CZ (1)	CZ271295A3 (pt)
DE (2)	DE4437406A1 (pt)
DK (1)	DK0708093T3 (pt)
ES (1)	ES2154311T3 (pt)
FI (1)	FI954946A7 (pt)
GR (1)	GR3035673T3 (pt)
HR (1)	HRP950524B1 (pt)
HU (1)	HUT73485A (pt)
IL (1)	IL115641A0 (pt)
MY (1)	MY132057A (pt)
NO (1)	NO306615B1 (pt)
NZ (1)	NZ280258A (pt)
PL (1)	PL184860B1 (pt)
PT (1)	PT708093E (pt)
SI (1)	SI9500329A (pt)
SK (1)	SK128495A3 (pt)
TW (1)	TW328954B (pt)
ZA (1)	ZA958783B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6369057B1 (en) *	1991-04-15	2002-04-09	Aventis Pharma Deutschland Gmbh	Quinoxalines, processes for their preparation and their use
US6015800A (en) *	1997-09-03	2000-01-18	Warner-Lambert Company	Substituted quinoxaline-2-ones as glutamate receptor antagonists
WO1999025327A2 (en) *	1997-11-14	1999-05-27	Warner-Lambert Company	Small molecule intervention in hiv-1 replication
GB9901795D0 (en) *	1999-01-28	1999-03-17	Glaxo Group Ltd	Chemical compounds
GB9911887D0 (en) *	1999-05-21	1999-07-21	Glaxo Group Ltd	Methods and medicaments for post exposure prophylaxis of an hiv infection
WO2002087500A2 (en) *	2001-04-27	2002-11-07	Newbiotics, Inc.	Viral enzyme activated prototoxophores and use of same to treat viral infections
WO2005018531A2 (en) *	2003-08-26	2005-03-03	'chemical Diversity Research Institute', Ltd.	Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
US7351709B2 (en) *	2004-06-09	2008-04-01	Wyeth	Estrogen receptor ligands
MX371331B (es)	2012-04-24	2020-01-27	Vertex Pharma	Inhibidores de la proteina cinasa dependiente de acido desoxirribonucleico(adn-pk).
ME03336B (me)	2013-03-12	2019-10-20	Vertex Pharma	Inhibitori dnk-pk
JP6408569B2 (ja)	2013-10-17	2018-10-17	バーテックスファーマシューティカルズインコーポレイテッドＶｅｒｔｅｘＰｈａｒｍａｃｅｕｔｉｃａｌｓＩｎｃｏｒｐｏｒａｔｅｄ	Ｄｎａ−ｐｋ阻害剤としての（ｓ）−ｎ−メチル−８−（１−（（２’−メチル−［４，５’−ビピリミジン］−６−イル）アミノ）プロパン−２−イル）キノリン−４−カルボキサミドおよびその重水素化誘導体の共結晶
EP3518931A4 (en)	2016-09-27	2020-05-13	Vertex Pharmaceuticals Incorporated	METHOD FOR TREATING CANCER WITH A COMBINATION OF DNA-DAMAGING SUBSTANCES AND DNA-PK INHIBITORS
AU2022303386A1 (en) *	2021-07-02	2023-12-14	Aldeyra Therapeutics, Inc.	Heterocyclic aldehyde trapping compounds and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE205837T1 (de) *	1991-04-15	2001-10-15	Aventis Pharma Gmbh	Chinoxaline, verfahren zu ihrer herstellung und ihre verwendung
DE4342024A1 (de) *	1993-12-09	1995-06-14	Hoechst Ag	Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid

1994
- 1994-10-19 DE DE4437406A patent/DE4437406A1/de not_active Withdrawn
1995
- 1995-10-12 EP EP95116094A patent/EP0708093B1/de not_active Expired - Lifetime
- 1995-10-12 AT AT95116094T patent/ATE198747T1/de not_active IP Right Cessation
- 1995-10-12 DK DK95116094T patent/DK0708093T3/da active
- 1995-10-12 DE DE59508969T patent/DE59508969D1/de not_active Expired - Fee Related
- 1995-10-12 ES ES95116094T patent/ES2154311T3/es not_active Expired - Lifetime
- 1995-10-12 PT PT95116094T patent/PT708093E/pt unknown
- 1995-10-15 IL IL11564195A patent/IL115641A0/xx unknown
- 1995-10-16 TW TW084110841A patent/TW328954B/zh active
- 1995-10-17 AU AU34316/95A patent/AU708293B2/en not_active Ceased
- 1995-10-17 US US08/544,290 patent/US5723461A/en not_active Expired - Fee Related
- 1995-10-17 MY MYPI95003112A patent/MY132057A/en unknown
- 1995-10-17 FI FI954946A patent/FI954946A7/fi unknown
- 1995-10-17 CZ CZ952712A patent/CZ271295A3/cs unknown
- 1995-10-17 NZ NZ280258A patent/NZ280258A/en unknown
- 1995-10-17 SK SK1284-95A patent/SK128495A3/sk unknown
- 1995-10-18 CN CN95120372A patent/CN1094930C/zh not_active Expired - Fee Related
- 1995-10-18 NO NO954139A patent/NO306615B1/no not_active IP Right Cessation
- 1995-10-18 HU HU9503005A patent/HUT73485A/hu unknown
- 1995-10-18 CA CA002160859A patent/CA2160859A1/en not_active Abandoned
- 1995-10-18 ZA ZA958783A patent/ZA958783B/xx unknown
- 1995-10-18 KR KR1019950035876A patent/KR960014108A/ko not_active Abandoned
- 1995-10-18 PL PL95311016A patent/PL184860B1/pl unknown
- 1995-10-18 HR HR950524A patent/HRP950524B1/xx not_active IP Right Cessation
- 1995-10-19 JP JP7271019A patent/JPH08225544A/ja active Pending
- 1995-10-19 BR BR9504456A patent/BR9504456A/pt not_active IP Right Cessation
- 1995-10-19 SI SI9500329A patent/SI9500329A/sl unknown
2001
- 2001-03-30 GR GR20010400523T patent/GR3035673T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU3431695A (en)	1996-05-02
BR9504456A (pt)	1997-05-20
NO954139L (no)	1996-04-22
FI954946L (fi)	1996-04-20
HRP950524B1 (en)	2002-06-30
JPH08225544A (ja)	1996-09-03
DE4437406A1 (de)	1996-04-25
SI9500329A (en)	1996-04-30
CZ271295A3 (en)	1996-08-14
EP0708093A1 (de)	1996-04-24
NO306615B1 (no)	1999-11-29
PT708093E (pt)	2001-06-29
FI954946A7 (fi)	1996-04-20
ATE198747T1 (de)	2001-02-15
SK128495A3 (en)	1996-06-05
MY132057A (en)	2007-09-28
GR3035673T3 (en)	2001-06-29
HK1011988A1 (en)	1999-07-23
DE59508969D1 (de)	2001-02-22
EP0708093B1 (de)	2001-01-17
AU708293B2 (en)	1999-07-29
NZ280258A (en)	1997-09-22
ZA958783B (en)	1996-05-09
CN1094930C (zh)	2002-11-27
FI954946A0 (fi)	1995-10-17
HU9503005D0 (en)	1995-12-28
PL184860B1 (pl)	2003-01-31
NO954139D0 (no)	1995-10-18
HRP950524A2 (en)	1997-10-31
CA2160859A1 (en)	1996-04-20
DK0708093T3 (da)	2001-04-30
TW328954B (en)	1998-04-01
US5723461A (en)	1998-03-03
ES2154311T3 (es)	2001-04-01
KR960014108A (ko)	1996-05-22
CN1135483A (zh)	1996-11-13
HUT73485A (en)	1996-08-28
PL311016A1 (en)	1996-04-29

Similar Documents

Publication	Publication Date	Title
ZA958783B (en)	1996-05-09	Quinoxalines a process for their preparation and their use
ES8602753A1 (es)	1985-12-01	Un procedimiento para la obtencion de agentes antibacteria- nos a base de acidos 7-amino-1-ciclopropil-6,8-difluor-1, 4-dihidro-4-oxo-3-quinolincarboxilicos
EP0342675A3 (en)	1990-12-27	Novel quinolonecarboxylic acid derivatives
HU9302696D0 (en)	1993-12-28	Process for producing aza quinoxaline derivatives and medical preparatives containing these compounds
GR3017651T3 (en)	1996-01-31	Quinolonecarboxylic acid derivative.
ES8405782A1 (es)	1984-06-16	Un procedimiento para la produccion de un derivado de carbostirilo.
GB9221220D0 (en)	1992-11-25	Organic componds
NZ290389A (en)	1999-03-29	Substituted pyrimidines typically substituted by -piperazin-1-yl
IL118368A (en)	1997-09-30	N-oxide quinoxaline derivatives
MX9708696A (es)	1998-08-30	Cefalosporinas antibacterianas.
HUT73973A (en)	1996-10-28	Substituted benzol-sulfonyl-ureas and thioureas, process for producing them, pharmaceutical or diagnostical use of them and pharmaceutical compositions containing them
EP0487996A3 (en)	1992-09-02	Cephalosporins substituted in position 3, process for their preparation and their use as medicine
ES8603175A1 (es)	1985-12-16	Procedimiento para preparar derivados de benzotiazol
ZA942970B (en)	1995-01-19	Pyrido(1,2,3-de)quinoxaline derivatives, process for their production and their use in pharmaceutical agents.
MX9705379A (es)	1997-10-31	Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora.
MX9705390A (es)	1997-10-31	Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de desordenes degenerativos cerebrales.
ES459473A1 (es)	1978-04-16	Procedimiento para la preparacion de nuevas 9-alcohilamino- eritromicinas.
ZA908309B (en)	1991-08-28	Dibenzodioxazecine and dibenzodioxaazacycloundecine derivatives
ES2005749A6 (es)	1989-03-16	Procedimiento para preparar un compuesto de cefem.
TW370460B (en)	1999-09-21	Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative...
PT87956A (pt)	1989-06-30	Processo para a preparacao de composicoes farmaceuticas anxioliticas contendo dosagens baixas de derivados de dioxopiperidina
MX9705214A (es)	1997-10-31	Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de hiperlipoproteinemia, hipertrigliceridemia, hiperlipidemia o hipercolesterolemia o arterioesclerosis o para el tratamiento anticoa